GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Price-to-Owner-Earnings

Merck KGaA (Merck KGaA) Price-to-Owner-Earnings : 25.47 (As of Apr. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Price-to-Owner-Earnings?

As of today (2024-04-26), Merck KGaA's share price is $32.345. Merck KGaA's Owner Earnings per Share (TTM) ended in Dec. 2023 was $1.27. It's Price-to-Owner-Earnings for today is 25.47.


The historical rank and industry rank for Merck KGaA's Price-to-Owner-Earnings or its related term are showing as below:

MKKGY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.66   Med: 19.7   Max: 32.88
Current: 25.94

During the past 13 years, the highest Price-to-Owner-Earnings of Merck KGaA was 32.88. The lowest was 8.66. And the median was 19.70.


MKKGY's Price-to-Owner-Earnings is ranked better than
53.68% of 421 companies
in the Drug Manufacturers industry
Industry Median: 27.64 vs MKKGY: 25.94

As of today (2024-04-26), Merck KGaA's share price is $32.345. Merck KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.40. Therefore, Merck KGaA's PE Ratio for today is 23.14.

As of today (2024-04-26), Merck KGaA's share price is $32.345. Merck KGaA's EPS without NRI for the trailing twelve months (TTM) ended in was $1.39. Therefore, Merck KGaA's PE Ratio without NRI for today is 23.27.

During the past 13 years, Merck KGaA's highest PE Ratio without NRI was 44.84. The lowest was 13.51. And the median was 27.10.


Merck KGaA Price-to-Owner-Earnings Historical Data

The historical data trend for Merck KGaA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Price-to-Owner-Earnings Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.79 24.38 28.63 25.38 24.19

Merck KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.38 24.97 23.02 26.68 24.19

Competitive Comparison of Merck KGaA's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Price-to-Owner-Earnings falls into.



Merck KGaA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Merck KGaA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=32.345/1.27
=25.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (OTCPK:MKKGY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Merck KGaA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (Merck KGaA) Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (Merck KGaA) Headlines

From GuruFocus

/C O R R E C T I O N -- EMD Serono/

By PRNewswire PRNewswire 05-14-2020